Clinical trial
Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress. A Proof-of-efficacy, Randomized, Controlled, Double-blind, Monocentric, Parallel Arms Design Study.
NCT04780763 is registered in ClinicalTrials.gov with Danone Global Research & Innovation Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress. A Proof-of-efficacy, Randomized, Controlled, Double-blind, Monocentric, Parallel Arms Design Study.
- Lead sponsor
- Danone Global Research & Innovation Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 4, 2021
- Completion date
- December 22, 2021
- Enrollment
- 168 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxious healthy subjects